Publication | Closed Access

A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy

Regenerative MedicineCell TherapyAmyotrophic Lateral SclerosisCellular TherapiesT-regulatory CellStem Cell TransplantationImmunologyTranslational ResearchStem-cell TherapyStem Cell TherapiesCell BiologyTherapeuticsImmunotherapyMedicineCell TransplantationAdoptive Cell TherapyRegulatory T Cell BiologyGood Manufacturing Practice–compliant